@article{houot:hal-04212634,
TITLE = {Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial},
AUTHOR = {Houot, Roch and Bachy, Emmanuel and Cartron, Guillaume and Gros, Fran{\c c}ois-Xavier and Morschhauser, Franck and Oberic, Lucie and Gastinne, Thomas and Feugier, Pierre and Dul{\'e}ry, R{\'e}my and Thieblemont, Catherine and Joris, Magalie and Jardin, Fabrice and Choquet, Sylvain and Casasnovas, Olivier and Brisou, Gabriel and Cheminant, Morgane and Bay, Jacques-Olivier and Gutierrez, Francisco Llamas and Menard, C{\'e}dric and Tarte, Karin and Delfau, Marie-H{\'e}l{\`e}ne and Portugues, C{\'e}dric and Itti, Emmanuel and Palard-Novello, Xavier and Blanc-Durand, Paul and Al Tabaa, Yassine and Bailly, Cl{\'e}ment and Laurent, Camille and Lemonnier, Fran{\c c}ois},
URL = {https://hal.science/hal-04212634},
JOURNAL = {Nature Medicine},
PUBLISHER = {Nature Publishing Group},
VOLUME = {29},
NUMBER = {10},
PAGES = {2593-2601},
YEAR = {2023},
MONTH = Sep, DOI = {10.1038/s41591-023-02572-5},
PDF = {https://hal.science/hal-04212634/file/s41591-023-02572-5.pdf},
HAL_ID = {hal-04212634},
HAL_VERSION = {v1},
}